• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Sneddon's syndrome and systemic lupus erythematosus with cerebrovascular disturbances and widespread livedo].

作者信息

Kalashnikova L A, Dobrynina L A, Reshetniak T M, Aleksandrova E A, Lozhnikova S M, Gulevskaia T S, Nasonov E L

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):21-5.

PMID:16117142
Abstract

A comparative clinical and instrumental analysis of 97 patients with Sneddon's syndrome (SS), a combination of cerebrovascular ischemic disturbances with widespread livedo, and 12 patients with systemic lupus erythematosus (SLE) with the same combination, has been conducted. Despite the presence of similar features related to antiphospholipid syndrome (APS)--cerebrovascular disturbances, livedo, fetal loss, peripheral venous thrombosis, thrombocytopenia, antibodies to phospholipids, etc--there were distinct differences between SS and SLE. In SS, no skin lesions ("butterfly", discoid lupus, photosensibilization) typical for SLE as well as sores of mucous oral cavity, polyarthritis, serosity, diagnostically significant titers of antinuclear factor and antibodies to DNA were observed. SS emerged with livedo (44%), cerebrovascular disturbances (24%) and systemic APS appearances (32%). SLE in 75% cases began with its classical symptoms and in 25% with systemic APS signs and never with livedo or cerebrovascular disturbances. For 10.5 +/- 8.0 years, no cases of SS were featured by typical SLE symptoms. Pathomorphological study indicated that SS and SLE were independent diseases. Their similarity was due to development of secondary APS, including cerebrovascular disturbances and livedo, in some patients with SLE.

摘要

相似文献

1
[Sneddon's syndrome and systemic lupus erythematosus with cerebrovascular disturbances and widespread livedo].
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):21-5.
2
[Neurological appearances of primary antiphospholipid syndrome].
Zh Nevrol Psikhiatr Im S S Korsakova. 2005(Suppl 13):19-24.
3
[Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].[网状青斑、脑血管疾病与二尖瓣疾病:Sneddon综合征的一个新病因?]
Ann Dermatol Venereol. 1990;117(12):925-30.
4
Sneddon's syndrome associated with anticardiolipin antibody: a case report.抗心磷脂抗体相关的斯内登综合征:一例报告。
Acta Neurol Belg. 1992;92(4):234-8.
5
The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus.斯内登综合征之谜:与抗磷脂综合征和系统性红斑狼疮的关系。
J Autoimmun. 2000 Sep;15(2):139-43. doi: 10.1006/jaut.2000.0418.
6
Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.系统性红斑狼疮和抗磷脂综合征孕妇抗核抗体和抗心磷脂抗体的纵向研究
Rheumatol Int. 2002 Aug;22(4):142-7. doi: 10.1007/s00296-002-0207-x. Epub 2002 Jun 19.
7
Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.斯内登综合征、抗心磷脂抗体与抗心磷脂辅助因子。病例报告。
Acta Neurol (Napoli). 1992 Apr;14(2):134-9.
8
Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.网状青斑与脑血管意外(斯内登综合征)作为抗磷脂综合征的一种临床表现。
J Eur Acad Dermatol Venereol. 1999 Mar;12(2):157-60.
9
Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?128例原发性抗磷脂综合征患者的长期随访:他们会发展为狼疮吗?
Medicine (Baltimore). 2005 Jul;84(4):225-230. doi: 10.1097/01.md.0000172074.53583.ea.
10
[Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].[90例抗磷脂综合征患者的抗体滴度及其与临床表现的相关性:疾病症状、一种新抗体及其与以色列人群临床表现的相关性]
Harefuah. 2001 Jun;140(6):495-500, 565.